Regeneron Pharmaceutical Releases Results of Phase 2 of the LUMINA-1 Trial

We are pleased to share this update from Regeneron Pharmaceuticals with Phase 2 results from the LUMINA-1 Trial.  

Make a Difference

Donate Connect Fundraise

Already a Member? Sign In

Sign Up for FOP Connection, Our Monthly eNewsletter